BD Biosciences Omics-One Protein Panels

BD Biosciences has launched three new Omics-One Protein Panels designed to substantially reduce the cost and complexity of performing single-cell multiomics, and specifically CITE-seq (cellular indexing of transcriptomes and epitopes by sequencing) studies, according to a company spokesperson. The new panels include:

• BD Omics-One Adaptive Protein Panel, a 59-plex antibody-oligo panel targeting key cell surface protein markers for characterizing cell populations and cell states associated with the adaptive immune system.
• BD Omics-One B-Cell Protein Panel, a 30-plex antibody-oligo panel targeting key cell surface protein markers on B cells such as CD19, CD20, HLA-DR and CD138, enabling the characterization of B-cell subtypes such as plasma cells, IgM memory cells, and germinal center B cells and their activated/suppressed states.
• BD Omics-One T-Cell Protein Panel, a 30-plex antibody panel targeting key cell surface protein markers on T cells such as CD3, CD4, CD8, CD45RO and CDRA, enabling the characterization of T-cell subtypes such as naïve, effector, and central memory T cells and their activated/suppressed states.